Medicine
Clinical efficacy and prognosis of DC-CIK cellular immunotherapy in the treatment of advanced renal cell carcinoma
Kong Dan-dan, Jiang Longwei, Z. Jie, Zhang Qi-ting, Zhang Yan, Ai Yueqin, Zhang Chuang, Zhao Hua, Gao Yanrong, Liao Wen-ming, Hui Jianhua, Jia Shaochang
tlooto Summary
DC-CIK cellular immunotherapy is a safe and effective treatment for patients with renal cell carcinoma and multiple treatments may improve the long-term survival rate of patients and serum cholesterol metabolism may affect tumor immunity.
Abstract
Abstract is not available.
Citation format
DAN-DAN, Kong, et al. Clinical efficacy and prognosis of DC-CIK cellular immunotherapy in the treatment of advanced renal cell carcinoma. Chinese Journal of Cancer Prevention and Treatment, 2018: 1515–1521.